Securities Class Action

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

Material Events

Critical Governance & Disclosure

5

Board, Voting & Shareholder Rights

7

Capital Structure & Financial Risk

2

Disclosure & Communications

13

SEC Filings

8-K

Current report

2026-11-03

View 8-K Current report on SEC.gov
8-K

Current report

2026-11-02

View 8-K Current report on SEC.gov
8-K

Current report

2026-10-22

View 8-K Current report on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-10-19

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
8-K

Current report

2026-10-14

View 8-K Current report on SEC.gov

Insider Transaction

No Insider Transactions found for Karyopharm Therapeutics Inc.